先天性细小病毒B19感染胎儿的结局:系统综述与荟萃分析
该系统综述与荟萃分析纳入35项观察性研究、611例先天性细小病毒B19感染胎儿,比较超声有或无水肿征象者的结局。水肿是死亡和不良围产结局的主要决定因素,无水肿胎儿围产结局总体良好。
要点
- 水肿胎儿流产风险(OR 11.5)和围产期死亡风险(OR 4.2)均高于无水肿胎儿。
- 无水肿胎儿感染自发消退率为49.6%,水肿胎儿仅5.2%。
- 水肿胎儿宫内输血后胎儿丢失风险高于无水肿胎儿(OR 9.8)。
核心结论
- 水肿是先天性细小病毒B19感染胎儿死亡和不良围产结局的主要决定因素。
- 无水肿胎儿的围产结局总体良好。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、EMBASE和CINAHL数据库,纳入35项观察性研究、共611例先天性细小病毒B19感染胎儿。
- 结局按超声有无水肿征象报告,并对<20周和≥20周诊断的水肿及无水肿胎儿进行亚组分析。
- 采用比例荟萃分析和个体数据随机效应逻辑回归荟萃分析。
主要发现
- 水肿胎儿流产风险高于无水肿胎儿(OR 11.5;95%CI 2.7-49.7),围产期死亡风险亦高于无水肿胎儿(OR 4.2;95%CI 1.6-11.0)。
- 水肿胎儿无需宫内输血的水肿自发消退率为5.2%(95%CI 2.5-8.8%),无水肿胎儿感染消退率为49.6%(95%CI 20.7-78.6%)。
- 水肿胎儿宫内输血率为78.7%(95%CI 66.4-88.8%),无水肿胎儿为29.6%(95%CI 6.0-61.6%);输血后感染消退率分别为55.1%(95%CI 34.0-75.3%)和100%(95%CI 57.3-100%)。
- 宫内输血后胎儿丢失风险水肿胎儿高于无水肿胎儿(OR 9.8;95%CI 2.8-34.6)。
- 异常脑影像发生率水肿胎儿为9.8%(95%CI 2.5-21.0%),无水肿胎儿为0.0%(95%CI 0.0-7.0%);异常神经发育结局发生率分别为9.5%(95%CI 2.6-20.2)和0.0%(95%CI 0.0-7.5%),但纳入病例数少,评估这些结局的统计效能不足。
局限性
- 评估异常脑影像和异常神经发育结局的统计效能不足,因纳入病例数少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the outcome of fetuses affected by congenital parvovirus B19 (PB19) infection, with or without signs of hydrops on ultrasound. METHODS: PubMed, EMBASE and CINAHL databases were searched for studies reporting on prenatal diagnosis and outcome of fetal PB19 infection. The outcomes explored were miscarriage, perinatal death (PND), intrauterine death, neonatal death, spontaneous resolution of hydrops or fetal anemia, need for intrauterine transfusion (IUT), resolution of hydrops or anemia after transfusion, fetal loss following transfusion, abnormal brain scan after birth and abnormal neurodevelopmental outcome. Outcomes were reported according to the presence or absence of signs of hydrops on ultrasound. A subgroup analysis was performed including hydropic and non-hydropic fetuses diagnosed at < 20 weeks and ≥ 20 weeks of gestation. Meta-analyses of proportions and meta-analyses using individual-data random-effects logistic regression were performed to analyze the data. RESULTS: Thirty-five observational studies were included, involving 611 fetuses affected by PB19 infection. The risks of miscarriage (odds ratio (OR), 11.5; 95% CI, 2.7-49.7) and PND (OR, 4.2; 95% CI, 1.6-11.0) were higher in fetuses with PB19 infection presenting, compared with those not presenting, signs of hydrops on ultrasound. In fetuses affected by hydrops, spontaneous resolution of the infection, defined as disappearance of hydrops without need for IUT, occurred in 5.2% (95% CI, 2.5-8.8%) of cases whereas, in the group of fetuses not affected by hydrops, infection resolved in 49.6% (95% CI, 20.7-78.6%) of cases. IUT was performed in 78.7% (95% CI, 66.4-88.8%) of hydropic and in 29.6% (95% CI, 6.0-61.6%) of non-hydropic fetuses affected by congenital PB19 infection and resolution of the infection after IUT occurred in 55.1% (95% CI, 34.0-75.3%) and in 100% (95% CI, 57.3-100%) of cases, respectively. The risk of fetal loss after IUT was higher in fetuses affected compared with those not affected by hydrops (OR, 9.8; 95% CI, 2.8-34.6). The prevalence of abnormal brain imaging was 9.8% (95% CI, 2.5-21.0%) in fetuses affected and 0.0% (95% CI, 0.0-7.0%) in those not affected by hydrops, whilst the corresponding figures for abnormal neurodevelopmental outcome were 9.5% (95% CI, 2.6-20.2) and 0.0% (95% CI, 0.0-7.5), respectively; however, statistical power to assess these outcomes was inadequate due to the small number of included cases. CONCLUSIONS: Hydrops is the main determinant of mortality and adverse perinatal outcome in fetuses with PB19 infection. Perinatal outcome in non-hydropic fetuses is generally favorable. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Bascietto F, Liberati M, Murgano D, et al. Outcome of fetuses with congenital parvovirus B19 infection: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018. PMID: 29785793. doi:10.1002/uog.19092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。